Clinical trial
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
NCT00042224 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00042224 |
|---|---|
| Title | Electroconvulsive Therapy in Clozapine Refractory Schizophrenia |
| Official title | ECT in Clozapine Refractory Schizophrenia |
| Lead sponsor | Northwell Health, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug, Procedure |
| Interventions | Electroconvulsive Therapy (ECT), Clozapine |
| Enrollment | 39 |
| Start date | Dec 1, 2000 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jul 26, 2002 |
| Last update posted | May 15, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: